This retrospective cohort study had aim to define and assess a cervical cancer screening cascade for women living with HIV enrolled at an ART clinic in Zimbabwe and to explore patient factors associated with retention through stages of the cascade. Main findings: Analysing outcomes along the proposed cervical screening cascade can identify areas for improvement; interventions are needed to improve linkage to treatment for screen-positive women who do not qualify for same-day cryotherapy; and many women continued to screen positive after treatment.
Do you have any questions? Contact us via email survey.cascade@gmail.com.
Funding
These activities are part of the project: Cervical Cancer Prevention and Care Cascade for women living with HIV in sub-Saharan Africa, that has received support from the Swiss Agency for Development and Cooperation; grant Advancing Cervical Cancer Screening in HIV-positive women (ACCHIVe) —The Cervical Cancer Prevention and Care Cascade (Award number: IZP8Z0_180245). The research is also supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD), National Institute Of Diabetes And Digestive And Kidney Diseases (NIDDK), National Heart, Lung, And Blood Institute (NHLBI), National Institute On Alcohol Abuse And Alcoholism (NIAAA), Fogarty International Center (FIC), National Cancer Institute (NCI), and by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number U01AI069924. We acknowledge the funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 801076 and support from the Federal Commission for Scholarships for Foreign Students for the Swiss Government Excellence Scholarship (ESKAS No. 2019.0741). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
